Biogen
BIIB
BIIB
950 hedge funds and large institutions have $25.9B invested in Biogen in 2022 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 318 increasing their positions, 388 reducing their positions, and 132 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $29.5B → $25.9B (-$3.65B)
18% less repeat investments, than reductions
Existing positions increased: 318 | Existing positions reduced: 388
37% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 132
Holders
950
Holding in Top 10
12
Calls
$789M
Puts
$798M
Top Buyers
| 1 | +$158M | |
| 2 | +$140M | |
| 3 | +$132M | |
| 4 |
BlackRock
New York
|
+$86.8M |
| 5 |
D.E. Shaw & Co
New York
|
+$86.3M |
Top Sellers
| 1 | -$513M | |
| 2 | -$112M | |
| 3 | -$111M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$109M |
| 5 |
Amundi
Paris,
France
|
-$99.2M |